Mehmet Ceyhan, Yasemin Ozsurekci, Sevgen Tanır Basaranoglu, Nezahat Gurler, Enes Sali, Melike Keser Emiroglu, Fatma Nur Oz, Nursen Belet, Murat Duman, Emel Ulusoy, Zafer Kurugol, Hasan Tezer, Aslinur Ozkaya Parlakay, Ener Cagri Dinleyici, Umit Celik, Solmaz Celebi, Ahmet Faik Oner, Mehmet Ali Solmaz, Adem Karbuz, Nevin Hatipoglu, Ilker Devrim, Ilknur Caglar, Sefika Elmas Bozdemir, Emine Kocabas, Ozlem Ozgur Gundeslioglu, Murat Sutcu, Ozge Metin Akcan, Necdet Kuyucu, Fesih Aktar, Soner Sertan Kara, Havva Ozlem Altay Akisoglu, Nilden Tuygun, Zeynep Diyar Tamburaci Uslu, Eda Karadag Oncel, Cihangul Bayhan, and Ali Bulent Cengiz
ABSTRACT The etiology of bacterial meningitis in Turkey changed after the implementation of conjugated vaccines against Streptococcus pneumoniae and Haemophilus influenzae type b (Hib) in the Turkish National Immunization Program (NIP). Administration of Hib vaccine and PCV-7 (7-valent pneumococcal conjugate vaccine) was implemented in NIP in 2006 and 2009, respectively. In 2011, PCV-7 was replaced with PCV-13. Meningococcal vaccines have not yet been included in Turkish NIP. This prospective study comprised 27 hospitals located in seven regions of Turkey and represented 45% of the population. Children aged between 1 month and 18 years who were hospitalized with suspected meningitis were included. Cerebrospinal fluid (CSF) samples were collected, and bacterial identification was made according to the multiplex PCR assay results. During the study period, 994 children were hospitalized for suspected meningitis, and Hib (n = 3, 2.4%), S. pneumoniae (n = 33, 26.4%), and Neisseria meningitidis (n = 89, 71%) were detected in 125 samples. The most common meningococcal serogroup was MenB. Serogroup W comprised 13.9% (n = 5) and 7.5% (n = 4) of the meningococci in 2015 to 2016 and 2017 to 2018, respectively. Serogroup C was not detected. There were four deaths in the study; one was a pneumococcus case, and the others were serogroup B meningococcus cases. The epidemiology of meningococcal diseases has varied over time in Turkey. Differing from the previous surveillance periods, MenB was the most common serogroup in the 2015-to-2018 period. Meningococcal epidemiology is so dynamic that, for vaccination policies, close monitoring is crucial. IMPORTANCE Acute bacterial meningitis (ABM) is one of the most common life-threatening infections in children. The incidence and prevalence of ABM vary both geographically and temporally; therefore, surveillance systems are necessary to determine the accurate burden of ABM. The Turkish Meningitis Surveillance Group has been performing a hospital-based meningitis surveillance study since 2005 across several regions in Turkey. Meningococcus was the major ABM-causing agent during the 2015-to-2018 period, during which MenB was the dominant serogroup.